Deutsche Bank’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.95M Buy
244,995
+23,127
+10% +$797K ﹤0.01% 1064
2026
Q1
$6.99M Buy
221,868
+7,099
+3% +$205K ﹤0.01% 1166
2025
Q4
$5.33M Buy
214,769
+59,873
+39% +$1.2M ﹤0.01% 1276
2025
Q3
$2.51M Buy
154,896
+7,371
+5% +$105K ﹤0.01% 1647
2025
Q2
$1.93M Sell
147,525
-228,535
-61% -$3.3M ﹤0.01% 1728
2025
Q1
$8.27M Buy
376,060
+100,223
+36% +$2.63M ﹤0.01% 1060
2024
Q4
$7.36M Buy
275,837
+57,955
+27% +$1.85M ﹤0.01% 1146
2024
Q3
$5.82M Buy
217,882
+186,768
+600% +$3.72M ﹤0.01% 1222
2024
Q2
$560K Buy
31,114
+5,840
+23% +$102K ﹤0.01% 2278
2024
Q1
$461K Buy
25,274
+4,864
+24% +$77.3K ﹤0.01% 2397
2023
Q4
$223K Sell
20,410
-687
-3% -$4.82K ﹤0.01% 2813
2023
Q3
$121K Buy
21,097
+3,177
+18% +$21.6K ﹤0.01% 3067
2023
Q2
$139K Sell
17,920
-5,677
-24% -$47.9K ﹤0.01% 3091
2023
Q1
$157K Buy
23,597
+6,960
+42% +$64.5K ﹤0.01% 3116
2022
Q4
$149K Buy
16,637
+4,573
+38% +$42.9K ﹤0.01% 3119
2022
Q3
$119K Sell
12,064
-1,991
-14% -$20.1K ﹤0.01% 3229
2022
Q2
$112K Sell
14,055
-7,941
-36% -$60K ﹤0.01% 3473
2022
Q1
$214K Sell
21,996
-2,498
-10% -$32.2K ﹤0.01% 3227
2021
Q4
$374K Buy
24,494
+17,124
+232% +$308K ﹤0.01% 3011
2021
Q3
$122K Buy
7,370
+25
+0.3% +$452 ﹤0.01% 3815
2021
Q2
$156K Buy
+7,345
New +$201K ﹤0.01% 3925

Other funds holding EWTX

Deutsche Bank's EWTX Position: Q2 2026 in Review

Deutsche Bank increased its Edgewise Therapeutics (EWTX) stake by 10% in Q2 2026, buying an estimated $797K and bringing the position to 244,995 shares worth $9.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Deutsche Bank first reported a position in EWTX in Q2 2021 and has held it in 21 quarters since. 64 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Deutsche Bank held 244,995 shares of Edgewise Therapeutics worth $9.95M as of Q2 2026.
  • Deutsche Bank bought 23,127 Edgewise Therapeutics shares in Q2 2026, an estimated $797K.
  • Edgewise Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1064 holding.
  • Deutsche Bank first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 64 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.